Print Page  Print Page | E-mail Alerts  E-mail Alerts | IR Contacts  IR Contact
<< Back

News Release


Quaker Chemical Corporation Announces Second Quarter Earnings and Investor Conference Schedule

    CONSHOHOCKEN, Pa., July 12 /PRNewswire-FirstCall/ -- Quaker Chemical
Corporation (NYSE: KWR) today announced the following schedule and contact
information for its second quarter 2004 earnings release and investor
conference:

    Earnings Release:      July 29, 2004 (after market close)
                           Visit Quaker Web site at http://www.quakerchem.com

    Teleconference:        July 30, 2004
                           10:30 a.m. (ET)
                           Participate live via telephone or listen to live
                           audio Webcast through Quaker's Web site at
                           http://www.quakerchem.com

    Dial-in Number:        877-269-7756 (toll free)
                           Please call 5-10 minutes prior to the scheduled
                           start of call.  No password required.

    If unable to participate live, select from one of the following replay
options:

    Phone Replay:          Available through Wednesday, August 4, 2004.
                           Call 877-660-6853 (toll free); Account 4022;
                           Replay Conference No. 109159

    Archived Webcast:      Visit Quaker's Web site at
                           http://www.quakerchem.com

Quaker Chemical Corporation, headquartered in Conshohocken, Pennsylvania, is a worldwide developer, producer, and marketer of custom-formulated chemical specialty products and a provider of chemical management services for manufacturers around the globe, primarily in the steel and automotive industries.

SOURCE  Quaker Chemical Corporation
    -0-                             07/12/2004
    /CONTACT:  Michael F. Barry, Vice President and Chief Financial Officer,
Quaker Chemical, +1-610-832-8500/
    /Web site:  http://www.quakerchem.com /
    (KWR)

CO:  Quaker Chemical Corporation
ST:  Pennsylvania
IN:  CHM
SU:  CCA MAV


MR 
-- PHM021 --
3012 07/12/2004 15:27 EDT http://www.prnewswire.com